DVA · News · 20260804N
Operating Income and Margins
DAVITA INC. · 2026-08-04 · Importance 52 · Surprise 56 · Contradicted
Second-quarter 2026 operating income reached $579 million, supported by higher dialysis treatment volumes and improved patient outcomes. Net income attributable to DaVita increased to $265 million from $199 million in the second quarter of 2025, a 33% year-over-year increase. Gross and operating margins declined as revenue per treatment fell, patient-care costs increased, and general and administrative expenses rose.
Key facts
- DaVita raised its 2026 guidance for adjusted operating income to between $2.15 billion and $2.25 billion. source
- Operating income for Q2 2026 was $579 million. source
- DaVita indicated higher general and administrative expenses contributed to a cautious market reaction after Q2 2026 results. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | positive | probable | +30.9% | DaVita raised its 2026 guidance for adjusted operating income to between $2.15 billion and $2.25 billion. |
| operating_income | unclear | realized | — | Operating income for Q2 2026 was $579 million. |